+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5592125
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Recombinant Proteins Market size was estimated at USD 5.05 billion in 2023, USD 5.80 billion in 2024, and is expected to grow at a CAGR of 14.51% to reach USD 13.04 billion by 2030.

Recombinant proteins involve research, development, manufacturing, and commercialization of genetically engineered proteins derived from recombinant DNA technology. The prevalence of infectious and chronic diseases, increasing healthcare expenditure needed for new therapeutics and diagnostics, and increased R&D investments within biopharmaceutical companies are raising the need for high-quality recombinant proteins. The rapid advancements in genomics technologies and growing adoption of biologics over small-molecule drugs are resulting in increased adoption of recombinant proteins. However, the high cost of production and maintenance may adversely impact the use of recombinant DNA by the end-use industries. In addition, the emerging applications in animal reproduction and to enhance feed efficiency and significant investments in recombinant protein development are the factors expected to encourage the use of these proteins by the end-use sectors worldwide.

Regional Insights

The recombinant protein market is evolving in the Americas owing to the presence of well-established pharmaceutical and biotech companies with advanced research facilities and regulations that ensure high-quality products. Additionally, technological advancements, significant increases in funding for research and development (R&D), the rising prevalence of chronic conditions, and a surge in demand for personalized medicines are resulting in an increased need for recombinant protein in the Americas. The EMEA region represents a developing landscape for the recombinant proteins market owing to the stringent regulations implemented to use these proteins and the requirement for manufacturers to adhere to GMP standards. The recombinant proteins market is growing in the APAC region due to the prevalence of chronic diseases, increased research activities in cell biology, biochemistry, structural and biophysical studies, and the need for efficient biopharmaceuticals. Moreover, technological advancements and collaborations between biopharmaceutical companies and academic institutions are expected to increase the translation of laboratory innovations into commercially viable products and boost the adoption of recombinant proteins by the end-use sectors across the globe.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Recombinant Proteins Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising focus on personalized medicine & protein therapeutics in the consumers
  • High prevalence of infectious & chronic diseases among geriatric population and children
  • Surging inclination of demand toward biologics and biosimilars proteins

Market Restraints

  • Concerns regarding time consumption coupled with high costs & maintenance of recombinant protein

Market Opportunities

  • Increasing focus on biomarker discovery and surging investments recombinant protein development
  • Growing potential for recombinant protein in animal reproduction, feed efficiency, and health

Market Challenges

  • Availability of alternative products and several issues in production

Market Segmentation Analysis

  • Product: Significant use of adhesion molecules & receptors for research purposes
  • Services: Expression services focus on high yields and compatibility with target protein characteristics
  • End-User: Extensive utilization of recombinant proteins in pharmaceutical and biopharmaceutical companies
  • Function: Potential demand of recombinant proteins for drug discovery & development

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Recombinant Proteins Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Recombinant Proteins Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

iTolerance and Northway Biotech Form Manufacturing Pact for Fusion Protein

U.S.-based iTolerance and Northway Biotech have agreed to manufacture Streptavidin-FasL (SA-FasL) fusion protein, a critical component of iTolerance's proprietary iTOL-100 platform technology. This collaboration is aimed to provide treatment options that have the potential to cure diseases without the need for chronic immunosuppression.

Biovian Invests Over EUR 50M in Manufacturing Facility in Finland

Biovian has invested EUR 50M in expanding its manufacturing facility in Turku, Finland, to offer end-to-end services, from development to commercial-scale production, for biopharmaceuticals. The new facility spans 6,400 m2 (69,000 ft2) and has advanced technologies and equipment to cater to Advanced Therapy Medicinal Products (ATMPs), including adenoviral and AAV therapies.

Fortis Life Sciences acquires International Point of Care

Fortis Life Sciences, LLC acquired International Point of Care, Inc.(IPOC) to provide customers with a comprehensive end-to-end solution for their immunodiagnostic and molecular diagnostic products. With this acquisition, Fortis can offer their customers top-quality materials and services that support advancements in ultra-high-sensitivity point-of-care diagnostics, multiplexing applications, quantitative lateral flow, isothermal amplification, and CRISPR-based diagnostics.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Recombinant Proteins Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Recombinant Proteins Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Bhat Bio-tech India Private Limited, Bio-Rad Laboratories, Inc., Biogen Inc., BioLegend, Inc. by PerkinElmer, Inc., Biologics International Corp, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Creative BioMart Inc., Croyez Bioscience Co., Ltd., Eli Lilly and Company, Enzo Life Sciences, Inc., Fortis Life Sciences LLC, GenScript Biotech Corporation, GeoVax Labs, Inc., Hzymes Biotech, Johnson & Johnson Services, Inc., Laurus Labs Limited, LenioBio GmbH, Lonza Group AG, Marin Biologic Laboratories, Inc., Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor Inc., Miltenyi Biotec B.V. & Co. KG, Novartis AG, ProMab Biotechnologies, Inc., Proteintech Group, Inc., Proteos, Inc., R&D Systems, Inc. by Bio-Techne Corporation, Sanofi S.A., Sartorius AG, Selvita S.A., Sino Biological, Inc., SK bioscience, Takara Bio Inc., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Recombinant Proteins Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Adhesion Molecules & Receptors
  • Growth Factors & Chemokines
  • Immune Response Proteins
  • Kinase Proteins
  • Membrane Proteins
  • Recombinant Metabolic Enzymes
  • Regulatory Proteins
  • Structural Proteins

Services

  • Cloning
  • Expression
  • Purification

End-User

  • Academic Research Institutes
  • Contract Research Organizations & Contract Manufacturing Organizations
  • Pharmaceutical & Biopharmaceutical Companies

Function

  • Diagnostics

Drug Discovery & Development

  • Biologics
  • Cell & Gene Therapy
  • Vaccines

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising focus on personalized medicine & protein therapeutics in the consumers
5.1.1.2. High prevalence of infectious & chronic diseases among geriatric population and children
5.1.1.3. Surging inclination of demand toward biologics and biosimilars proteins
5.1.2. Restraints
5.1.2.1. Concerns regarding time consumption coupled with high costs & maintenance of recombinant protein
5.1.3. Opportunities
5.1.3.1. Increasing focus on biomarker discovery and surging investments recombinant protein development
5.1.3.2. Growing potential for recombinant protein in animal reproduction, feed efficiency, and health
5.1.4. Challenges
5.1.4.1. Availability of alternative products and several issues in production
5.2. Market Segmentation Analysis
5.2.1. Product: Significant use of adhesion molecules & receptors for research purposes
5.2.2. Services: Expression services focus on high yields and compatibility with target protein characteristics
5.2.3. End-User: Extensive utilization of recombinant proteins in pharmaceutical and biopharmaceutical companies
5.2.4. Function: Potential demand of recombinant proteins for drug discovery & development
5.3. Market Trend Analysis
5.3.1. Increase in research spending coupled with healthcare infrastructure across Americas
5.3.2. Prevalence of chronic diseases and significant investments in medical research in the APAC region
5.3.3. Expanding drug manufacturing facilities and regulatory guidelines for recombinant protein in the EMEA region.
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
6. Recombinant Proteins Market, by Product
6.1. Introduction
6.2. Adhesion Molecules & Receptors
6.3. Growth Factors & Chemokines
6.4. Immune Response Proteins
6.5. Kinase Proteins
6.6. Membrane Proteins
6.7. Recombinant Metabolic Enzymes
6.8. Regulatory Proteins
6.9. Structural Proteins
7. Recombinant Proteins Market, by Services
7.1. Introduction
7.2. Cloning
7.3. Expression
7.4. Purification
8. Recombinant Proteins Market, by End-User
8.1. Introduction
8.2. Academic Research Institutes
8.3. Contract Research Organizations & Contract Manufacturing Organizations
8.4. Pharmaceutical & Biopharmaceutical Companies
9. Recombinant Proteins Market, by Function
9.1. Introduction
9.2. Diagnostics
9.3. Drug Discovery & Development
10. Americas Recombinant Proteins Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Recombinant Proteins Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Recombinant Proteins Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. iTolerance and Northway Biotech Form Manufacturing Pact for Fusion Protein
13.3.2. Biovian Invests Over EUR 50M in Manufacturing Facility in Finland
13.3.3. Fortis Life Sciences acquires International Point of Care
13.3.4. Curia Expands Cell Line Development Offering with CHOZN Platform
13.3.5. Future Fields raises USD 11.2 million to scale up fruit flies for recombinant protein production
13.3.6. Merck’s Biodevelopment Centre Expansion, Martillac, France
13.3.7. Shenandoah Biotechnology Introduces Expanded Range of CTGrade Recombinant Proteins Manufactured Following cGMP Practices
13.3.8. Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
13.3.9. Thermo Fisher Scientific Completes Acquisition of PeproTech, engaged in Recombinant Proteins
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. RECOMBINANT PROTEINS MARKET RESEARCH PROCESS
FIGURE 2. RECOMBINANT PROTEINS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RECOMBINANT PROTEINS MARKET DYNAMICS
FIGURE 7. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 10. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RECOMBINANT PROTEINS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. RECOMBINANT PROTEINS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. RECOMBINANT PROTEINS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ADHESION MOLECULES & RECEPTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ADHESION MOLECULES & RECEPTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROWTH FACTORS & CHEMOKINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROWTH FACTORS & CHEMOKINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IMMUNE RESPONSE PROTEINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IMMUNE RESPONSE PROTEINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY KINASE PROTEINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY KINASE PROTEINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MEMBRANE PROTEINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MEMBRANE PROTEINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RECOMBINANT METABOLIC ENZYMES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RECOMBINANT METABOLIC ENZYMES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGULATORY PROTEINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGULATORY PROTEINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY STRUCTURAL PROTEINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY STRUCTURAL PROTEINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CLONING, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CLONING, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BIOLOGICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 87. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 90. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 91. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 94. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 95. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 96. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 97. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 100. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 101. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 104. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 105. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 106. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 138. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 141. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 144. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 145. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 148. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 149. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 150. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 151. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 154. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 155. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 156. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 157. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 158. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 159. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 160. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 168. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 171. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 174. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 175. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 178. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 179. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 180. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 188. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 198. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 208. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 218. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 228. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 231. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 234. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 235. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 238. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 239. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 240. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 248. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 263. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 266. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 267. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 270. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 271. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 272. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 273. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 276. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 277. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 278. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 279. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 280. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 281. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 282. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 283. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 286. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 287. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 290. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 291. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 292. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 293. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 296. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 297. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 300. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 301. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 302. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 303. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 306. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 307. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 308. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 309. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 310. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 311. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 312. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 319. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 320. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 323. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 326. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 327. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 328. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 329. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 330. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 331. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2023 (USD MILLION)
TABLE 332. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2024-2030 (USD MILLION)
TABLE 333. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 334. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 335. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 336. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 337. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 340. NETHERLANDS RECOMBINANT PROTEINS M

Companies Mentioned

  • Abcam PLC
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Bhat Bio-tech India Private Limited
  • Bio-Rad Laboratories, Inc.
  • Biogen Inc.
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Biologics International Corp
  • BPS Bioscience, Inc.
  • Bristol-Myers Squibb Company
  • Creative BioMart Inc.
  • Croyez Bioscience Co., Ltd.
  • Eli Lilly and Company
  • Enzo Life Sciences, Inc.
  • Fortis Life Sciences LLC
  • GenScript Biotech Corporation
  • GeoVax Labs, Inc.
  • Hzymes Biotech
  • Johnson & Johnson Services, Inc.
  • Laurus Labs Limited
  • LenioBio GmbH
  • Lonza Group AG
  • Marin Biologic Laboratories, Inc.
  • Merck KGaA
  • Meridian Bioscience, Inc. by SD Biosensor Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Novartis AG
  • ProMab Biotechnologies, Inc.
  • Proteintech Group, Inc.
  • Proteos, Inc.
  • R&D Systems, Inc. by Bio-Techne Corporation
  • Sanofi S.A.
  • Sartorius AG
  • Selvita S.A.
  • Sino Biological, Inc.
  • SK bioscience
  • Takara Bio Inc.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information